Related Experiment Video
Updated: Jun 21, 2026

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
Published on: July 8, 2025
[The peculiarities of epilepsy in the menopause]
Abstract:
Twenty seven cases with the combination of epilepsy and menopause are presented. The menopause proved to be a critical period for epilepsy manifestation: in 44.4% women with epilepsy the disease onset was observed at the peri- and post-menopause period. The course of epilepsy during this period was less severe: the frequency of seizures increased in 7.4% and decreased in 33.3%, no changes in the frequency of seizures were observed in 59.3%. The severity of menopause syndrome was not correlated with duration and severity of epilepsy, 81.4% of patients had the mild severity of this syndrome. The reduction of bone density was found in most of women (85.2%). It implies that all patients with epilepsy and menopause should receive a prophylactic treatment to prevent osteopenia. About 18.6% of patients required the hormone replacement therapy but only 7.4% received it due to adverse effects.
More Related Videos
09:06Manipulation of Epileptiform Electrocorticograms (ECoGs) and Sleep in Rats and Mice by Acupuncture
Published on: December 22, 2016
10:22Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Published on: December 6, 2016
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures l: Introduction
Epilepsy ll: Types
Menopause
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...